It’s worth it to have a look at Aclaris Therapeutics, Inc. (NASDAQ:ACRS) as there may be a chasm between the bulls and the bears as far as recent trading activity goes. Now trading with a market value of 205.89M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Fundamentals […]
Full Post at eglobalist.com